Eli Casdin, Director, 10% Owner at STANDARD BIOTOOLS INC. (LAB), bought 500,000 shares at $1.28 ($638K) on 2025-09-04, disclosed to the SEC on 2025-09-05.
Open-market purchase of $638k LAB by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.27 | 250,000 | $318K | 49.8% |
| 2 | $1.28 | 250,000 | $320K | 50.2% |
| Total | $1.27 avg | 500,000 | $638K | 100% |
| Filing → |
| LAB | BUY | 2025-08-15 | $604K | — | Filing → |
| BLFS | SELL | 2025-08-13 | $11.3M | — | Filing → |
| BLFS | SELL | 2025-06-12 | $23.8M | — | Filing → |